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Exploration of new source of antibiotics to combat multidrug-resistant bacteria is urgently needed. Indonesia as 
archipelago country has a wide variety of marine organisms with potential as source of new antibacterial compounds 
against MDRO. Aims of the study were to isolate sponge-associated fungi from sponge Cinachyrella sp. collected 
from Pandang Island, North Sumatera, Indonesia, to screen potential fungi against clinical pathogenic MDR bacteria, 
to identify the potential fungi; and to determine the best cultivation time for antibacterial production. Nine sponge-
associated fungi were successfully isolated. Result of agar plug method showed fungus PDSP 5.7 was the most potential 
candidate which inhibited ESBL Escherichia coli, Salmonella enterica ser. Typhi, MRSA, and Staphylococcus 
haemolyticus strain MDR. This fungus had 100% similarity to Trichoderma reesei. In malt extract broth, T. reesei 
PDSP 5.7 had stationary phase from day 12 to day 18. In addition, the widest antibacterial was performed by extract 
from day 15. Furthermore, fungal extract showed best antibacterial activity against S. enterica ser. Typhi strain MDR 
with inhibition value of 14.72 ± 0.07 mm2.
Key words:
Antibacterial, associated 
fungi, MDR, Trichoderma. 
INTRODUCTION
The massive number of multidrug-resistant organisms 
(MDRO) infections nowday is caused by the irrational use of 
antibiotic in several decades ago (Alanis, 2005; de Simone et 
al., 2016; Cansizoglu and Toprak, 2017). Several pathogenic 
bacteria such as extended-spectrum beta-lactamase (ESBL) E. 
coli, methicillin-resistant S. aureus (MRSA), Staphylococcus 
haemolyticus, and Salmonella enterica ser. Typhi have been 
isolated from patients and identified as infectious MDRO 
(Hosseinkhani et al., 2016; Goudarzi et al., 2017; Lugito and 
Cucunawangsih, 2017; Shakya et al., 2017). As MDRO, these 
bacteria are resistant to antibiotics so that the urgency of finding 
the new antibiotic candidate has become very important. 
Previous studies discovered new antibacterial compounds 
from marine organisms such as algae, coral and sponge (Liu et al., 
2014; Abdel-Raouf et al., 2015; Nguyen et al., 2017). Among all 
marine organisms, sponge is the most studied as source of bioactive 
compounds (Mehbub et al., 2014; Kumar and Pal, 2016). Beesoo 
et al. (2017) reported extract from Neopetrosia exigua contained 
beta-sitosterol and cholesterol. This extract inhibited S. aureus 
and Bacillus cereus with MIC and MBC values of 0.039 mg/mL 
and 0.078 mg/mL. Furthermore, Wright et al. (2017) isolated 
dragmacidin G from Spongosorites sp. with broad spectrum 
antibacterial activity against S. aureus and Mycobacterium 
tuberculosis. At the same year, Nguyen et al. (2017) successfully 
discovered langcoquinone C and smenospongorine from Spongia 
sp. which had significant antibacterial against B. subtilis and 
S. aureus with MICs ranging from 6.25 to 25 µM. Admittedly, 
exploration of new antibiotics candidate from sponges leads to 
environmental issue. So that, the utilization of their associated 
microorganisms is commonly applied.
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Marine sponge-associated fungi are also known as 
a potential source for discovery of new antibiotic candidate 
(Handayani and Artasasta, 2017; Sibero et al., 2017). In addition, 
several discoveries were successfully isolate new compounds 
from sponge-associated fungi with biological activities (Zin et al., 
2016; Noinart et al., 2017). Furthermore, Liu et al. (2017) isolated 
11 compounds from sponge-derived fungus Aspergillus sydowii 
J05B-7F-4. Among 11 compounds, there were 5 diphenylethers 
which had antibacterial activity against human pathogen S. 
aureus. Fungus Pestalotiopsis heterocornis which isolated from 
sponge Phakellia fusca was reported to produce isocumarins 1-3. 
These compounds had antibacterial activity against S. aureus and 
B. subtilis with MIC values ranging from 25 to 100 µg/mL (Lei 
et al. 2017). Unfortunatelly, there are a few researches which 
study antibacterial activity of sponge-associated fungi against 
multidrug-resistant bacteria. Aims of the study were to isolate 
sponge-associated fungi from sponge Cinachyrella sp. collected 
from Pandang Island, North Sumatera, to screen potential fungi 
against clinical pathogenic MDR bacteria, to identify the potential 
fungi, and to determine the best cultivation time for antibacterial 
production.
MATERIAL AND METHODS
Sponge Cinachyrella sp.
Sponge Cinachyrella sp. was collected from Pandang 
Island, North Sumatera, Indonesia from a depth of 2 m by 
snorkeling. After the collection, approximietly 5 × 5 cm2 
sample was cut and kept in sterile zip lock plastic for fungal 
isolation.
Clinical pathogenic MDR bacteria
The clinical pathogenic MDR bacteria used in this 
study were clinical collections from Dr. Kariadi General Hospital 
Medical Center, Semarang, Central Java, Indonesia. ESBL E. coli, 
MRSA, S. haemolyticus and S. enterica ser. Typhi were used as 
test bacteria. ESBL and S. enterica ser. Typhi were re-cultured 
on MacConkey M081B agar from HiMedia while MRSA and S. 
haemolyticus were re-cultured on Nutrient Agar CM0003 from 
Oxoid Ltd. at 37oC for 24 h.
Fungal isolation and purification
This study applied surface sterilization methods from 
Kjer et al. (2010) and Sibero et al. (2017) for fungal isolation 
with several modifications. Firstly, sponge was cut into 3 pieces 
in size 2 × 1 cm2 and washed using sterile marine water then was 
immersed in alcohol 70% for 60 s. After that, sponge was washed 
using sterile marine water to clean the alcohol residue. Lastly, each 
piece was tapped on a Malt Extract Agar (MEA) M137 HiMedia 
as a control of quality of surface sterilization method before placed 
on other MEA and incubated for 7 days (27oC). During fungal 
isolation, a petri dish with MEA was opened as an environmental 
control. The fungal growth was observed daily. Each mycelium 
which grew on sponge was isolated and transferred to a new 
medium for further step.
Antibacterial activity screening of sponge-associated fungi
Agar plug method was carried out for antibacterial 
activity screening. All fungal isolates were refreshed on MEA 
for 7 days at 27oC while MDR bacteria were re-cultured for 24 
h at 37oC and diluted to be 0.5 McFarland in physiological saline 
solution. After that, MDR dilution was inoculated on Mueller 
Hinton Agar (MHA) from Merck KGaA. Each fungus with its 
agar medium were cut in circle shape then placed on an inoculated 
MHA medium and incubated for 24 h at 37oC. Antibacterial 
activity was indicated by the presence of clear zone around fungal 
colony (Rahaweman et al., 2016; Sibero et al., 2017). Fungal 
isolate which able inhibited all tested bacteria was used for the 
further step as potential fungus.
Table 1: Antibacterial activity of sponge-associated fungi.
Fungal 
Isolate
Presence of inhibition zone
ESBL E. coli S. enterica ser. Typhi MRSA S. haemolyticus
PDSP 5.1 - - + +
PDSP 5.2 - - - -
PDSP 5.3 - - - -
PDSP 5.4 + - - -
PDSP 5.5 - - - -
PDSP 5.6 - - - -
PDSP 5.7 + + + +
PDSP 5.8 + - - +
PDSP 5.9 + - - +
(+: presence of inhibition zone; -: absence of inhibition zone).
Fungal identification
Identification through macro-microscopic and molecular 
approaches was carried for this study. Fungus was grown on MEA 
for 7 days. Microscopic characterization was done using slide 
culture method (Qiu et al., 2005). Furthermore, mycelia were 
taken for DNA extraction using Chelex 100 method. For DNA 
amplification, PCR mix was consisted of 12.5 μL of GoTaq 
Green Master mix from Promega Corporation, 1 μL of ITS 1, 
1 μL of ITS 4, 10 μL of ddH2O and 0.5 μL of DNA template. 
In addition, primer ITS1 (5′-TCC GTA GGT GAA CCT GCG 
G-3′) and ITS4 (5′-TCC TCC GCT TAT TGA TAT GC-3′) from 
Macrogen were applied. Fungal DNA was amplified with these 
following conditions: cDNA preheat at 95oC for 3 m, 30 cycles of 
denaturation at 95oC for 1 min, annealing at 51.80oC for 1 min and 
extension at 72oC for 1 min while the post cycling extension was 
done at 72oC for 7 min. PCR product was sequenced by 1st BASE 
DNA Laboratories Sdn Bhd, Malaysia. Lastly, phylogenetic three 
of potential fungus was reconstructed using MEGA.7 software 
package (Sibero et al., 2017).
Fungal cultivation in broth medium for antibacterial assay 
and growth curve
Potential fungus was cultivated in 250 mL of Malt 
Extract Broth (MEB) from DifcoTM for 21 days at 27oC. Fungus 
was harvested every three days. Fungal mycelia were separated 
using filter paper (Advantec 7, Ø 125 mm). Filter paper had been 
dried in oven at 50oC for 24 h and weighed before used as blank 
(Wo). After separation, filter papers contained mycelia were dried 
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in oven (50oC) for 24 h then weighed (Wt). Mycelial weights was 
obtained using following simple mathematical formula and used 
to construct fungal growth curve while the broth media was used 
for further step. pH of media in each harvesting day was measured 
using pH meter.
                              Wm = Wt − Wo
Extraction of fungal metabolite
Ethyl acetate was used for extraction of fungal 
metabolite. The ratio of media to solvent was 1:2 (v/v). Solvent 
were separated from media using separatory funnel then the 
solvent were evaporated using rotary evaporator at 37oC.
Table 2: Antibacterial activity of fungal extract from different harvesting 
time.
Bacteria Day Inhibition Zone (mm) 
ESBL E. coli
3 0.00 ± 0.00a
6 3.25 ± 0. 07b
9 4.20 ± 0.28c
12 5.45 ± 0.49d
15 9.09 ± 0.14g*
18 8.20 ± 0.00f
21 7.58 ± 0.16e
S. enterica ser. Typhi
3 0.00 ± 0.00a
6 2.40 ± 0.09b
9 3.37 ± 0.72c
12 10.76 ± 0.04d
15 14.78 ± 0.07f*
18 14.64 ± 0.06f
21 13.47 ± 0.04e
MRSA
3 0.00 ± 0.00a
6 3.05 ± 0.28b
9 4.56 ± 0.14c
12 5.28 ± 0.07d
15 7.40 ± 0.14f*
18 7.25 ± 0.04f
21 7.09 ± 0.02e
S. haemolyticus
3 0.00 ± 0.00a
6 2.20 ± 0.01b
9 3.38 ± 0.01c
12 3.89 ± 0.14d
15 6.81 ± 0.11g*
18 6.48 ± 0.07f
21 6.24 ± 0.02e
(Data are mean ± SD. Values with different shared letters in each MDR denote 
significant difference at P < 0.05. Values with * denote the highest antibacterial 
activity in each MDR bacteria).
In vitro antibacterial assay of fungal extract
Fungal extract was diluted to 50 µg/mL, 125 µg/mL, 250 
µg/mL, 500 µg/mL and 1000 µg/mL then tested against ESBL E. 
coli, MRSA, S. haemolyticus and S. enterica ser. Typhi according 
to CLSI (2016). The bacteria were inoculated on MHA using 
sterile cotton bud then 10 µL of each concentration was injected 
into the paper disc (Ø 6 mm OxoidTM) and placed onto the MHA 
medium then incubated for 24 h at 32oC. Amoxicillin + Clavulanic 
acid (30 µg/disc, Ø 6 mm OxoidTM) was used as positive control. 
The presence of clear zone indicated the antibacterial activity. 
Determination of antibacterial activity was done with two 
replications.
Data analysis
Data were analyzed using factorial design in SPSS 
software package version 18.0 for Windows with confidence 
interval 95% (P < 0.05).
Table 3: Antibacterial activity of fungal extract at 15 days of cultivation.
Bacteria Day Inhibition Zone (mm)
ESBL E. coli
50 4.13 ± 0.06a
125 5.30 ± 0.28b
250 8.72 ± 0.07c
500 8.83 ± 0.08c
1000 9.10 ± 0.14c
Amoxicillin + Clavulanic acid 12.50 ± 0.14d*
S. enterica ser. 
Typhi
50 8.19 ± 0.02a
125 8.49 ± 0.04a
250 11.90 ± 0.42b
500 14.40 ± 0.15c
1000 14.72 ± 0.07c*
Amoxicillin + Clavulanic acid 12.20 ± 0.28b
MRSA
50 5.03 ± 0.02a
125 7.59 ± 0.14b
250 7.75 ± 0.21b
500 8.40 ± 0.14c
1000 8.97 ± 0.09d*
Amoxicillin + Clavulanic acid 8.86 ± 0.04d
S. haemolyticus
50 5.09 ± 0.16a
125 7.60 ± 0.23b
250 8.10 ± 0.14c
500 8.21 ± 0.00c
1000 9.04 ± 0.20d
Amoxicillin + Clavulanic acid 10.25 ± 0.07e*
(Data are mean ± SD. Values with different shared letters in each MDR denote 
significant difference at P < 0.05. Values with * denote the highest antibacterial 
activity in each MDR bacteria).
RESULT AND DISCUSSION
There were 9 sponge associated fungi isolated from 
Cinachyrella sp. Each fungus had been screened against four 
clinical pathogenic MDR. During its growth on agar medium, 
fungus PDSP 5.7 secreted extracellular metabolites into medium. 
In agar plug method, fungal MEA medium contained extracellular 
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metabolite were plugged on agar medium inoculated with tested 
MDR bacteria. In incubation time, fungal extracellular metabolites 
diffused from plug to the agar medium to kill tested MDR bacteria. 
The appearance of inhibition zone around the agar plug indicated 
the antibacterial activity (Balouiri et al., 2016; Rahaweman 
et al., 2016; Sibero et al., 2017). This study used ESBL E. coli 
and S. enterica ser. Typhi as representatives of gram negative 
bacteria while MRSA and S. haemolyticus as representatives of 
gram positive bacteria. The result of the screening with agar plug 
method is presented by Table 1.
Fig. 1: Morphological characteristics of fungus PDSP 5.7. (a. top side, b. reverse side, c. conidiophore, d. conidia, e. hyphae).
Fig. 2: Phylogram of genetic distance of fungus PDSP 5.7 using ITS rRNA region.
Table 1 shows 5 fungi which had antibacterial 
activity against clinical pathogenic MDR bacteria. Fungus 
PDSP 5.1 showed antibacterial activity against gram positive 
MDR, fungus PDSP 5.4 only showed antibacterial activity 
against ESBL E. coli, fungus PDSP 5.8 and PDSP 5.9 inhibited 
ESBL E. coli and S. haemolyticus. By contrast, fungus PDSP 
5.7 had antibacterial activity against all tested MDR bacteria. 
Therefore, fungus PDSP 5.7 was selected as potential isolate 
and used further steps.
As a potential isolate, fungus PDSP 5.7 was identified 
with macro-microscopic and molecular approaches. Figure 1 (a-b) 
show fungal colony on MEA. It had white colony with green 
circular pattern on the middle of it. At room temperature (27oC), 
this fungus produced yellow extracellular pigment which secreted 
into the agar medium. Figure 1 (c-e) show fugal microscopic 
morphology of fungus PDSP 5.7. This fungus had branching 
conidiophore with lageniform phialides, conidia ellipsodial nearly 
to oblong and septum in hyphae. These characteristics leaded 
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fungus PDSP 5.7 to be judge as member of genus Trichoderma 
(Rahman et al., 2011; Qin and Zhuang 2016; Sibero et al. 2017). 
Molecular analysis was done for the further identification. The 
phylogenetic tree of fungus PDSP 5.7 is shown by Figure 2.
The phylogram shows the homology comparison of 
fungus PDSP 5.7 to several Trichoderma species. This fungus 
had 100% similarity to Trichoderma reesei KU377472.1. Fungi 
from genus Trichoderma are commonly isolated as sponge-
associated fungi (Sibero et al., 2016; Mohamed-Benkada et al., 
2016; Pang et al., 2017). T. reesei MPS 14.5/MT 04 was also 
found as fungal associate in Cinachyrella sp. from Panjang Island, 
Jepara, Indonesia with antibacterial activity (Sibero et al., 2017). 
Antibacterial activity from microorganisms is strongly related to 
its life phases (Tarman et al., 2013; Indarmawan et al. 2016; Ukhty 
et al., 2017). Fungus PDSP 5.7 has been registered in GeneBank 
as Trichoderma reesei with accession number MG547722.1. A 
growth curve is important to determine fungal life phase. Growth 
curve of T. reesei PDSP 5.7 is presented by Figure 3.
Fig. 3: Growth and pH curves of fungus PDSP 5.7 in MEB for 21 days of 
cultivation.
Fungus PDSP 5.7 passed log phase at day 3 to day 9, while 
stationary phase started at day 12 to day 18. The highest biomass of 
dry mycelia was produced at day 15 (0.5180 ± 0.001 gr) Usually, 
microorganisms produce secondary metabolites in stationary phase. 
Tarman et al. (2013) stated that endophytic fungi from Rhizophora 
mucronata produced the highest bioactive compounds on day 15 
in PDB-based medium. Meanwhile, marine algicolous fungus 
Xylaria psidii KT30 produced the highest metabolite activity 
during stationary phase on day 21 in Hagem-based medium. 
Nutrient content in broth medium related to the fungal growth phase 
(Ukhty et al., 2017). Malt extract broth (MEB) used in this study 
as fermentation medium contain malt extract as carbon source and 
mycological peptone as nitrogen source. Sánchez et al. (2010) noted 
that carbon source has important role on antibiotic production. 
The pH of broth medium decreased during log phase then stable 
at stationary phase. It was caused by the fermentation done by the 
fungi (Indarmawan et al., 2016). Antibacterial activity of fungal 
extract in each harvesting time is shown by Table 2. For this step, 
fungal extracts were diluted to 1000 µg/mL.
Diameter of inhibition zone from fungal extracts 
increased from day 3 to day 15 (Table 1). Day 15 had the highest 
inhibition zone against all clinical pathogenic MDR bacteria so 
that, we proposed 15 days as the optimum cultivation time for 
fungus T. reesei PDSP 5.7. As shown in Figure 2, day 15 was 
known as stationary phase of fungus T. reesei PDSP 5.7. We noted 
that, this fungus strongly inhibited Salmonella enterica ser. Typhi 
followed by ESBL E. coli, then S. haemolyticus and MRSA. The 
ability of fungus against gram negative and positive MDR bacteria 
indicated a broad spectrum antibacterial activity. Several studies 
reported that fungi demonstrated widest antibacterial activity in 
stationary phase (Tarman et al., 2013; Indarmawan et al., 2016; 
Ukhty et al., 2017). In stationary phase, fungi produce particular 
bioactive compounds to protect themselves from competitors 
(Manavathu and Vazquez, 2014). Furthermore, fungal extract 
from day 15 was dilluted to be 50 µg/mL, 125 µg/mL, 250 µg/
mL, 500 µg/mL and 1000 µg/mL then tested against ESBL E. coli, 
MRSA, S. haemolyticus and S. enterica ser. Typhi. The result of 
this assay is presented by Table 2 and Figure 4.
Fig. 4: Inhibition zone from fungal extract T. reesei PDSP 5.7 against (a) 
ESBL E. coli, (b) S. enterica ser. Typhi, (c) MRSA, (d) S. haemolyticus.
The range of inhibition zone value from fungal extract 
which harvested at day 15 was 4.13 ± 0.06 to 14.72 ± 0.07 (Table 
2). The widest inhibition zone was performed by concentration 
1000 µg/mL against S. enterica ser. Typhi, moreover this 
inhibition zone was wider than Amoxicillin + Clavulanic acid as 
positive control. In addition, this extract showed no significantly 
different (P < 0.05) against MRSA compared to positive control. 
The genus Trichoderma were known as potential source of 
polypeptide which has antibacterial activity. Panizel et al. (2013) 
stated that T. atrovorode isolated from sponge Axinella produced 
peptaibols with antibacterial activity against environmental 
bacteria such as Sporosarcina sp. (NB90); Bacillus sp. (NB36), 
Shewanella sp. (III.07) and Microbacterium sp. (PII.14). Fungus 
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T. longibrachiatum MMS151 from blue mussels produced six 
long-chain peptaibols. Two of six long-chain peptaibols showed 
noticeable cytotoxic activity against KB cells, antibacterial 
activity against gram positive bacteria and antifungal activity 
against human pathogenic Aspergillus fumigatus (Mohamed-
Benkada et al., 2016). Moreover, T. parareesei from Indonesian 
marine sponge produced yellow pigment which inhibited E. coli 
and S. enterica ser. Typhi strain MDR (Sibero et al., 2016). Beside 
polypeptides, Trichoderma members also produced polyketide 
compounds such as trichodermatides A-D, trichoderpyrone and 
trichoketides A and B with various biological activities (Sun et al., 
2008; Yamazaki et al., 2015; Chen et al., 2017). For the further 
research, isolation of lead compounds from fungus T. reesei PDSP 
5.7 is suggested to obtain the next generation of antibiotic.
CONCLUSION
There were nine sponge-associated fungi isolated from 
sponge Cinachyrella sp. Result of agar plug method showed fungus 
PDSP 5.7 was the most potential fungi which inhibited all tested 
MDR bacteria. Macro-microscopic and molecular identification 
judged this fungus as Trichoderma reesei MG547722.1. Fifteen 
day of cultivation was proposed as optimal time for cultivation of 
fungus T. reesei PDSP 5.7 MG547722.1. Fungal extract showed 
best antibacterial activity against S. enterica ser. Typhi, followed 
by ESBL E. coli, S. haemolyticus then MRSA.
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